Clinical Trial Update: Single-dose Crossover Study to Compare the Safety and Efficacy of FlutiForm With Fluticasone and Formoterol Concurrently or Alone in Asthma Patients [Phase 2]

View source ↗

Summary

A completed Phase 2 single-dose crossover trial evaluated the safety and efficacy of FlutiForm compared with Fluticasone + Formoterol given concurrently or Flut…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• FlutiForm (fluticasone propionate/formoterol)
• Fluticasone (fluticasone propionate)
• Formoterol (formoterol)

Snippet

Sponsor: SkyePharma AG | Conditions: Asthma | Phase 2 | Status: COMPLETED